|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:D4053 Batch: D405306
Enfortumab vedotin-ejfv (Padcev) is an antibody-drug conjugate (ADC) composed of an fully human anti-Nectin-4 IgG1 kappa monoclonal antibody (AGS-22C3), conjugated to Monomethyl Auristatin E (MMAE), via a protease-cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl. Enfortumab vedotin-ejfv has the potential for use in research of urothelial carcinoma.
| CAS No. | 1346452-25-2 |
|---|---|
| Formulation | 100 mM Pro-Ac, 20 mM Arg, pH 5.0 |
| DAR | 3.6 |
| ADC antiody | Enfortumab |
| ADC cytotoxin | MMAE |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 9.656mg/ml |
| Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。